Your browser doesn't support javascript.
loading
Molecular Bases of the Membrane Association Mechanism Potentiating Antibiotic Resistance by New Delhi Metallo-ß-lactamase 1.
Prunotto, Alessio; Bahr, Guillermo; González, Lisandro J; Vila, Alejandro J; Dal Peraro, Matteo.
Affiliation
  • Prunotto A; Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Bahr G; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • González LJ; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), S2000EXF Rosario, Argentina.
  • Vila AJ; Area Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, S2002LRK Rosario, Argentina.
  • Dal Peraro M; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), S2000EXF Rosario, Argentina.
ACS Infect Dis ; 6(10): 2719-2731, 2020 10 09.
Article in En | MEDLINE | ID: mdl-32865963
Resistance to last-resort carbapenem antibiotics is an increasing threat to human health, as it critically limits therapeutic options. Metallo-ß-lactamases (MBLs) are the largest family of carbapenemases, enzymes that inactivate these drugs. Among MBLs, New Delhi metallo-ß-lactamase 1 (NDM-1) has experienced the fastest and largest worldwide dissemination. This success has been attributed to the fact that NDM-1 is a lipidated protein anchored to the outer membrane of bacteria, while all other MBLs are soluble periplasmic enzymes. By means of a combined experimental and computational approach, we show that NDM-1 interacts with the surface of bacterial membranes in a stable, defined conformation, in which the active site is not occluded by the bilayer. Although the lipidation is required for a long-lasting interaction, the globular domain of NDM-1 is tuned to interact specifically with the outer bacterial membrane. In contrast, this affinity is not observed for VIM-2, a natively soluble MBL. Finally, we identify key residues involved in the membrane interaction with NDM-1, which constitute potential targets for developing therapeutic strategies able to combat resistance granted by this enzyme.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Beta-Lactamases / Carbapenems Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Beta-Lactamases / Carbapenems Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2020 Type: Article